Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 13
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/1/1990
1.
Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: Aminothiadiazole in Patients with Uterine Sarcoma (Summary Last Modified 12/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
GOG-26Q
GOG-26Q
2.
Master Protocol for Phase II Evaluation of New Agents for Unresectable non-Small Cell Lung Cancer --- Aminothiadiazole
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D82-012-1031
ICC-81L2
Last Modified:
4/26/2007
3.
Phase II Master Protocol for Chemotherapy for Recurrent or Stage IV Renal Cell Carcinoma --- VBL vs L-Alanosine vs Acivicin vs CTX vs Misonidazole vs Aminothiadiazole
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-1882
4.
Phase II Master Protocol for Evaluation of New Agents for Previously Treated Metastatic Breast Cancer --- AT-125, A-TDA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-2182
5.
Phase II Master Protocol Chemotherapy with New Agents for Metastatic or Recurrent Colorectal Cancer --- ATDA vs ICRF-187 vs SPG and CHIP vs CBDCA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-4282
6.
Phase II Master Protocol for Chemotherapy with New Agents for Metastatic or Recurrent Adenocarcinoma of the Colon or Rectum --- ATDA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D82-012-1346
ICC-79I2
Last Modified:
11/7/2007
7.
Phase II Chemotherapy with 2-Aminothiadiazole in Patients with Inoperable non-Small Cell Carcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI-W82-1276
CTEPIS-0059, W82-1276
Last Modified:
1/1/1990
8.
Phase II Master Protocol for Chemotherapy with New Agents for Advanced non-Hodgkin's Lymphoma --- ATDA (Summary Last Modified 01/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
ICC-83H2
NCI-T83-0924D, T83-0924
9.
Phase II Master Protocol Evaluation of Single-Agent or Combination Chemotherapy for Advanced Squamous Cell Carcinoma of the Esophagus --- ATDA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
EST-1284
Last Modified:
5/1/1989
10.
Phase II Chemotherapy with Aminothiadiazole in Patients with Advanced Colorectal Carcinoma (Summary Last Modified 05/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-88I2
NCI-T88-0068D, T88-0068
Select All on One Page
1
2
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
